Literature DB >> 18483743

Prognosis of upper-third gastric carcinoma patients with invasion of the lower esophagus.

Seong Yeob Ryu1, Jae Kyoon Joo, Jae Hyuk Lee, Dong Yi Kim.   

Abstract

BACKGROUND AND AIMS: Epidemiological studies show a continuing rise in the prevalence of upper-third gastric carcinoma. We compared the clinicopathologic features and prognosis in these patients, with and without lower esophageal invasion. PATIENTS AND METHODS: We reviewed the hospital records of 42 patients with lower esophageal invasion seen between 1986 and 2000.
RESULTS: Borrmann type IV gastric carcinoma was more frequently found in patients with esophageal invasion (P < 0.001). Multivariate analysis indicated that curability, the extent of lymph node dissection, and lymph node metastases were significant prognostic factors. When the patients with esophageal invasion were divided into those with or without curative resection, the 5-year survival rates were 37.3% and 0%, respectively (P < 0.001). In patients with lymph node dissection above the D2 lymph node, the 5-year survival rate was higher than that of patients with dissection below the D2 node level (34.4% vs 0%, P < 0.001).
CONCLUSION: According to our results, curative resection and extensive lymph node dissection were the determining factors in improving survival.

Entities:  

Mesh:

Year:  2008        PMID: 18483743     DOI: 10.1007/s00423-008-0344-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  20 in total

1.  Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

2.  Surgical treatment of adenocarcinoma of the cardia.

Authors:  S Stipa; A Di Giorgio; M Ferri
Journal:  Surgery       Date:  1992-04       Impact factor: 3.982

Review 3.  Surgical treatment of gastric cancer invading the oesophagus.

Authors:  F Bozzetti; P Bignami; L Bertario; S Fissi; M Eboli
Journal:  Eur J Surg Oncol       Date:  2000-12       Impact factor: 4.424

4.  Cardia carcinoma considered as a distinct clinical entity.

Authors:  B Husemann
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

5.  Adenocarcinoma in the upper third part of the stomach.

Authors:  T Okamura; S Tsujitani; P Marin; M Haraguchi; D Korenaga; H Baba; K Sugimachi
Journal:  Surg Gynecol Obstet       Date:  1987-09

6.  Prognostic factors in adenocarcinoma in the upper one-third of the stomach.

Authors:  Y Maehara; S Moriguchi; Y Kakeji; H Orita; M Haraguchi; D Korenaga; K Sugimachi
Journal:  Surg Gynecol Obstet       Date:  1991-09

7.  Adenocarcinoma of the gastric cardia. The choice of gastrectomy.

Authors:  D N Papachristou; J G Fortner
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

8.  Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

9.  Time trends in gastric carcinoma: changing patterns of type and location.

Authors:  M E Craanen; W Dekker; P Blok; J Ferwerda; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1992-05       Impact factor: 10.864

10.  Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  S Ohno; S Tomisaki; H Oiwa; Y Sakaguchi; Y Ichiyoshi; Y Maehara; K Sugimachi
Journal:  J Am Coll Surg       Date:  1995-05       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.